Home > Insider Trading > Filing (0001104659-24-077877)

Filing Details

Accession Number:: 0001104659-24-077877
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-07-03 21:31:39
Reporting Period:: 2024-07-01

Accepted Time:: 2024-07-03 21:31:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1847367	Alumis Inc.	ALMS	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
2027905	Foresite Labs, Llc	601 California Street Suite 600 San Francisco CA 94108		No	No	Yes	No
2028005	Foresite Labs Affiliates 2021, Llc	601 California Street Suite 600 San Francisco CA 94108		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-07-01	1,944,577	$0.00	1,944,577	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2024-07-01	1,122,994	$0.00	3,067,571	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2024-07-01	560,076	$0.00	3,627,647	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2024-07-01	622,344	$0.00	4,249,991	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2024-07-01	1,022,398	$0.00	5,272,389	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2024-07-01	312,500	$16.00	5,584,889	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2024-07-01	194,459	$0.00	194,459	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2024-07-01	481,283	$0.00	481,283	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2024-07-01	560,076	$0.00	1,041,359	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2024-07-01	311,172	$0.00	1,352,531	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2024-07-01	681,598	$0.00	2,034,129	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2024-07-01	967,567	$0.00	967,567	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2024-07-01	311,172	$0.00	1,278,739	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2024-07-01	681,598	$0.00	1,960,337	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2024-07-01	311,172	$0.00	311,172	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2024-07-01	1,703,998	$0.00	2,015,170	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2024-07-01	2,187,500	$16.00	4,202,670	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series Seed Redeemable Convertible Preferred Stock	Disposition	2024-07-01	1,944,577	$0.00	1,944,577	$0.00
Common Stock	Series Seed Redeemable Convertible Preferred Stock	Disposition	2024-07-01	194,459	$0.00	194,459	$0.00
Common Stock	Series A Redeemable Convertible Preferred Stock	Disposition	2024-07-01	1,122,994	$0.00	1,122,994	$0.00
Common Stock	Series A Redeemable Convertible Preferred Stock	Disposition	2024-07-01	481,283	$0.00	481,283	$0.00
Common Stock	Series B-1 Redeemable Convertible Preferred Stock	Disposition	2024-07-01	560,076	$0.00	560,076	$0.00
Common Stock	Series B-1 Redeemable Convertible Preferred Stock	Disposition	2024-07-01	560,076	$0.00	560,076	$0.00
Common Stock	Series B-1 Redeemable Convertible Preferred Stock	Disposition	2024-07-01	967,567	$0.00	967,567	$0.00
Common Stock	Series B-2 Redeemable Convertible Preferred Stock	Disposition	2024-07-01	622,344	$0.00	622,344	$0.00
Common Stock	Series B-2 Redeemable Convertible Preferred Stock	Disposition	2024-07-01	311,172	$0.00	311,172	$0.00
Common Stock	Series B-2 Redeemable Convertible Preferred Stock	Disposition	2024-07-01	311,172	$0.00	311,172	$0.00
Common Stock	Series B-2 Redeemable Convertible Preferred Stock	Disposition	2024-07-01	311,172	$0.00	311,172	$0.00
Common Stock	Series C Redeemable Convertible Preferred Stock	Disposition	2024-07-01	1,022,398	$0.00	1,022,398	$0.00
Common Stock	Series C Redeemable Convertible Preferred Stock	Disposition	2024-07-01	681,598	$0.00	681,598	$0.00
Common Stock	Series C Redeemable Convertible Preferred Stock	Disposition	2024-07-01	1,703,998	$0.00	1,703,998	$0.00
Common Stock	Series C Redeemable Convertible Preferred Stock	Disposition	2024-07-01	681,598	$0.00	681,598	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,176,470	Indirect	See Footnote

Footnotes

Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date.
The shares are held of record by Foresite Capital Fund V, L.P. ("Fund V"). Foresite Capital Management V, LLC ("FCM V") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum ("Tananbaum"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a "group", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and, other than Fund V, disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities.
The shares are held of record by Labs Co-Invest V, LLC ("Labs Co-Invest"). FCM V is the managing member of Labs Co-Invest and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a "group", as defined in Rule 13d-5 of the Exchange Act, and, other than Labs Co-Invest, disclaims beneficial ownership of the shares held by Labs Co-Invest, except to the extent of such person's pecuniary interest in such securities.
The shares are held of record by Foresite Capital Opportunity Fund V, L.P. ("Opportunity Fund V"). Foresite Capital Opportunity Management V, LLC ("FCOM V") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a "group", as defined in Rule 13d-5 of the Exchange Act, and, other than Opportunity Fund V, disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities.
The shares are held of record by Foresite Labs Fund I, L.P. ("Labs Fund I"). Foresite Labs Management I, LLC ("FLM I") is the general partner of Labs Fund I and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FLM I, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a "group", as defined in Rule 13d-5 of the Exchange Act, and, other than Labs Fund I, disclaims beneficial ownership of the shares held by Labs Fund I, except to the extent of such person's pecuniary interest in such securities.
The shares are held of record by Foresite Capital Fund VI, L.P. ("Fund VI"). Foresite Capital Management VI, LLC ("FCM VI") is the general partner of Fund VI and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCM VI, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a "group", as defined in Rule 13d-5 of the Exchange Act, and, other than Fund VI, disclaims beneficial ownership of the shares held by Fund VI, except to the extent of such person's pecuniary interest in such securities.
The shares are held of record by Foresite Labs Affiliates 2021, LLC ("Labs Affiliates"). Foresite Labs, LLC ("Labs") is the managing member of Labs Affiliates and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, a manager of Labs, may be deemed to share voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a "group", as defined in Rule 13d-5 of the Exchange Act, and, other than Lab Affiliates, disclaims beneficial ownership of the shares held by Labs Affiliates, except to the extent of such person's pecuniary interest in such securities.